NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
VAZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/11/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
10/25/2022
Registration date
06/11/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/12/2017
First use in commerce
12/12/2017
Drawing code
3
Owner type
99
Owner location
NANJING, JIANGSU, CN
Examiner
WOOD, DANIEL
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of two sets of four prongs intersecting in the middle, followed by the wording "VAZYME".
Holders and representatives
Holders
Vazyme Biotech Co., Ltd.
Representatives
JOHN ALUMIT
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Disinfectants; Vaccines; Chemical preparations for pharmaceutical or medical purposesfor treating cardiovascular diseasesinfectious diseaseschronic diseasesreproductive issuesimproving kidney function and stomach function; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Pharmaceutical preparations for treating cardiovascular diseasesinfectious diseases and chronic diseases; Reagents for use in medical genetic testing; Vaccine preparations; Chemically treated papers for use in the detection of fecal occult blood; Preparations of microorganisms for medical purposes
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/16/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/15/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/15/2023
CNSL
SUSPENSION LETTER WRITTEN
08/15/2023
DOCK
ASSIGNED TO EXAMINER
08/09/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2022
NWAP
NEW APPLICATION ENTERED
10/28/2022
Continuous trademark protection
Get notified about every new filing that threatens VAZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.